Comparative responsiveness of the EuroQol‐5D and Short Form 6D to improvement in patients with rheumatoid arthritis treated with tumor necrosis factor blockers: Results of the Dutch Rheumatoid Arthritis Monitoring registry

Abstract Objective For cost‐utility analyses of health technologies, utilities are commonly measured with the EuroQol‐5D (EQ‐5D) or the Short Form 6D (SF‐6D). Although most studies in rheumatoid arthritis (RA) found the SF‐6D to be more responsive than the EQ‐5D, evidence is not convincing. The aim of this study was to compare the responsiveness of the EQ‐5D and SF‐6D to improvement in RA patients treated with tumor necrosis factor (TNF) blockers. Methods Data from 278 RA patients included in the Dutch Rheumatoid Arthritis Monitoring registry were used. Internal responsiveness over 1 year was... Mehr ...